IF 5.7 2区 医学 Q1 IMMUNOLOGY
Frontiers in Immunology Pub Date : 2025-03-19 eCollection Date: 2025-01-01 DOI:10.3389/fimmu.2025.1539780
Christopher J Papayannakos, Mohd Israr, James A DeVoti, Fung Lam, Arnon Arazi, Douglas K Frank, Dev P Kamdar, Lucio M Pereira, Nagashree Seetharamu, Bettie M Steinberg, Vincent R Bonagura
{"title":"Oropharyngeal carcinomas induce circulating monocytes to express a TAM-like pro-tumor expression profile that suppresses T-cell proliferation.","authors":"Christopher J Papayannakos, Mohd Israr, James A DeVoti, Fung Lam, Arnon Arazi, Douglas K Frank, Dev P Kamdar, Lucio M Pereira, Nagashree Seetharamu, Bettie M Steinberg, Vincent R Bonagura","doi":"10.3389/fimmu.2025.1539780","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Tumor-associated macrophages (TAMs) recruited from circulating monocytes drive tumor-growth and establish an immunosuppressive tumor microenvironment (TME). Initial events in transition from resting monocytes to TAMs are poorly understood. Here, we report that monocytes from oropharyngeal cancer (OPC) patients and control monocytes treated with OPC-conditioned media (CM) express a repertoire of pro-tumor mediators that is characteristic of TAMs.</p><p><strong>Methods: </strong>Monocytes were stimulated with OPC cell line CM, analyzed by single-cell RNAseq. Results of select genes were confirmed by qPCR with monocytes and analyzed in OPC tumors vs. clinically normal tissue. OPC spheroids containing control monocytes and T-cells were established, TAM phenotype characterized by flow analysis and qPCR, and T-cell proliferation assessed by flow.</p><p><strong>Results: </strong>OPC-conditioned media induced multiple pro-tumor genes including <i>CXCL1, CXCL5, CXCL8, SPP1, IL1B, GPNMB</i>, and <i>FABP5</i>. Patient monocytes had higher baseline levels or achieved higher levels after stimulation than control monocytes. A subset of patient monocytes had high baseline levels of <i>CXCL9/-10/-11</i> expression that resisted downregulation in response to stimulation, a potential sign of a more favorable TME. <i>CXCL9/-10/-11</i> expression in OPC tumor biopsies compared to clinically normal tissue correlated with patient outcome. Spheroid TAMs derived from control monocytes maintained the pro-tumor repertoire seen with monocytes stimulated by tumor line conditioned media. These TAMs suppress T-cell proliferation. Inhibition of COX-2 or IL1 signaling during differentiation into TAMs partially blocked the suppression of T-cell proliferation.</p><p><strong>Conclusion: </strong>Targeting the early transition of monocytes into pro-tumor TAMs could be used to develop new therapies for OPC.</p>","PeriodicalId":12622,"journal":{"name":"Frontiers in Immunology","volume":"16 ","pages":"1539780"},"PeriodicalIF":5.7000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11961958/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2025.1539780","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

引言从循环单核细胞中招募来的肿瘤相关巨噬细胞(TAMs)会推动肿瘤生长并建立免疫抑制性肿瘤微环境(TME)。人们对静息单核细胞向 TAM 过渡的初始事件知之甚少。在这里,我们报告了口咽癌(OPC)患者的单核细胞和用 OPC 条件培养基(CM)处理的对照单核细胞表达了 TAMs 所特有的一系列促肿瘤介质:用 OPC 细胞系 CM 刺激单核细胞,并通过单细胞 RNAseq 进行分析。通过与单核细胞进行 qPCR,确认所选基因的结果,并分析 OPC 肿瘤与临床正常组织的对比。建立了含有对照单核细胞和 T 细胞的 OPC 球体,通过流式分析和 qPCR 鉴定了 TAM 表型,并通过流式分析评估了 T 细胞增殖:结果:OPC调节介质诱导多种促肿瘤基因,包括CXCL1、CXCL5、CXCL8、SPP1、IL1B、GPNMB和FABP5。与对照组单核细胞相比,患者单核细胞的基线水平更高,或在刺激后达到更高水平。一部分患者单核细胞的 CXCL9/-10/-11 表达基线水平较高,在受到刺激后可抵抗下调,这是 TME 更有利的潜在迹象。与临床正常组织相比,CXCL9/-10/-11在OPC肿瘤活检组织中的表达与患者的预后相关。从对照单核细胞中提取的球状 TAMs 保持了受肿瘤系条件培养基刺激的单核细胞所表现出的亲肿瘤序列。这些 TAMs 可抑制 T 细胞增殖。在分化成 TAMs 的过程中抑制 COX-2 或 IL1 信号传导可部分阻断对 T 细胞增殖的抑制:结论:针对单核细胞早期转变为亲肿瘤 TAM 的过程,可用于开发治疗 OPC 的新疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Oropharyngeal carcinomas induce circulating monocytes to express a TAM-like pro-tumor expression profile that suppresses T-cell proliferation.

Introduction: Tumor-associated macrophages (TAMs) recruited from circulating monocytes drive tumor-growth and establish an immunosuppressive tumor microenvironment (TME). Initial events in transition from resting monocytes to TAMs are poorly understood. Here, we report that monocytes from oropharyngeal cancer (OPC) patients and control monocytes treated with OPC-conditioned media (CM) express a repertoire of pro-tumor mediators that is characteristic of TAMs.

Methods: Monocytes were stimulated with OPC cell line CM, analyzed by single-cell RNAseq. Results of select genes were confirmed by qPCR with monocytes and analyzed in OPC tumors vs. clinically normal tissue. OPC spheroids containing control monocytes and T-cells were established, TAM phenotype characterized by flow analysis and qPCR, and T-cell proliferation assessed by flow.

Results: OPC-conditioned media induced multiple pro-tumor genes including CXCL1, CXCL5, CXCL8, SPP1, IL1B, GPNMB, and FABP5. Patient monocytes had higher baseline levels or achieved higher levels after stimulation than control monocytes. A subset of patient monocytes had high baseline levels of CXCL9/-10/-11 expression that resisted downregulation in response to stimulation, a potential sign of a more favorable TME. CXCL9/-10/-11 expression in OPC tumor biopsies compared to clinically normal tissue correlated with patient outcome. Spheroid TAMs derived from control monocytes maintained the pro-tumor repertoire seen with monocytes stimulated by tumor line conditioned media. These TAMs suppress T-cell proliferation. Inhibition of COX-2 or IL1 signaling during differentiation into TAMs partially blocked the suppression of T-cell proliferation.

Conclusion: Targeting the early transition of monocytes into pro-tumor TAMs could be used to develop new therapies for OPC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.80
自引率
11.00%
发文量
7153
审稿时长
14 weeks
期刊介绍: Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信